The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Cyclopropanesulfonic acid{4-[4-((R)-pyrrolidin-3-ylamino)-thieno[3,2-d]pyrimidin-2-yl]-pyridin-2-yl}-amide ID: ALA3728643
PubChem CID: 89596384
Max Phase: Preclinical
Molecular Formula: C18H20N6O2S2
Molecular Weight: 416.53
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=S(=O)(Nc1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccn1)C1CC1
Standard InChI: InChI=1S/C18H20N6O2S2/c25-28(26,13-1-2-13)24-15-9-11(3-7-20-15)17-22-14-5-8-27-16(14)18(23-17)21-12-4-6-19-10-12/h3,5,7-9,12-13,19H,1-2,4,6,10H2,(H,20,24)(H,21,22,23)/t12-/m1/s1
Standard InChI Key: JBYHAFIQCAXEEH-GFCCVEGCSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
-2.5827 5.3949 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6222 5.9944 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-3.6215 4.7944 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9971 -3.0138 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.2935 -3.7700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4279 -5.2511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8944 -5.5664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6474 -4.2692 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6464 -3.1521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6168 1.4950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9144 0.7421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2151 1.4892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2185 2.9892 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.9211 3.7421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6204 2.9950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9214 5.2429 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6225 7.4952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3727 8.7026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8727 8.7029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
8 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 9 1 0
8 9 2 0
9 10 1 0
10 11 1 0
11 12 2 0
12 8 1 0
7 13 1 0
14 13 1 6
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 14 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
5 19 1 0
23 25 1 0
25 2 1 0
2 26 1 0
27 26 1 0
28 27 1 0
26 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 416.53Molecular Weight (Monoisotopic): 416.1089AlogP: 2.43#Rotatable Bonds: 6Polar Surface Area: 108.90Molecular Species: BASEHBA: 8HBD: 3#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.60CX Basic pKa: 10.31CX LogP: 0.68CX LogD: 0.28Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.57Np Likeness Score: -1.74
References 1. (2013) Thienopyrimidine inhibitors of atypical protein kinase C,